[-] Show simple item record

dc.contributor.authorLyon, Coreyeng
dc.contributor.authorReed, Alexeng
dc.contributor.authorPrasad, Shailendraeng
dc.contributor.otherUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.date.issued2017-08eng
dc.description.abstractA recent study evaluated the effectiveness of 3 direct oral anticoagulants and warfarin in patients with atrial fibrillation. So which agents came out on top? PRACTICE CHANGER: Use direct oral anticoagulants instead of warfarin in patients with atrial fibrillation because they are just as effective at preventing ischemic stroke and systemic emboli as warfarin, and because apixaban and dabigatran have lower bleeding rates. Stength of recommendation: B: Based on a single, prospective, cohort study.eng
dc.identifier.citationJournal of Family Practice, 66(8) 2017: 518-520.eng
dc.identifier.urihttps://hdl.handle.net/10355/61539
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofPriority Updates to Research Literature (PURLs)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectoral anticoagulants, warfarin, atrial fibrillation, ischemic stroke, systemic emboli, apixaban, dabigatran, bleeding rateseng
dc.titleDirect oral anticoagulants or warfarin for A fib?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record